Pharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitagliptin in middle-aged obese subjects.
Herman GA, Bergman A, Liu F, Stevens C, Wang AQ, Zeng W, Chen L, Snyder K, Hilliard D, Tanen M, Tanaka W, Meehan AG, Lasseter K, Dilzer S, Blum R, Wagner JA.
Herman GA, et al. Among authors: meehan ag.
J Clin Pharmacol. 2006 Aug;46(8):876-86. doi: 10.1177/0091270006289850.
J Clin Pharmacol. 2006.
PMID: 16855072
Clinical Trial.